A bioluminescent reporter bioassay for in-process assessment of chimeric antigen receptor lentiviral vector potency
{{output}}
Background: Chimeric antigen receptor (CAR)-T-cell therapy is a breakthrough in the field of cancer immunotherapy, wherein T cells are genetically modified to recognize and attack cancer cells. Delivery of the CAR gene is a criti... ...
